Login / Signup

Optimizing home-based long-term intensive care for neurological patients with neurorehabilitation outreach teams - protocol of a multicenter, parallel-group randomized controlled trial (OptiNIV-Study).

Thomas PlatzThomas KohlmannSteffen FleßaBernadette EinhäuplMartha KoppelowLina WillackerHans-Jürgen GdyniaEsther HenningJürgen HerzogFriedemann MüllerDennis A NowakRomy PletzFelix SchlachetzkiTobias Schmidt-WilckeMichael SchüttlerAndreas StraubeRebekka SüssVolker ZieglerAndreas Bender
Published in: BMC neurology (2022)
The trial OptiNIV has been registered in the German Clinical Trials Register (DRKS) since 18.01.2022 with the ID DRKS00027326 .
Keyphrases
  • randomized controlled trial
  • clinical trial
  • study protocol
  • phase ii
  • phase iii
  • double blind
  • colorectal cancer screening